With shares of Goldman Sachs (NYSE:GS) trading around $166, is GS an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementGoldman Sachs is engaged in investment banking, securities, and investment management. It provides a range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments, and high net worth individuals. The company operates in four segments: investment banking, institutional client services, investing and lending, and investment management. Through its segments, Goldman Sachs provides valuable investment services to consumers and companies worldwide.
Goldman Sachs has lost a complicated bet it made on the foreign-exchange market, leading to a drop in revenue for the third-quarter and forcing executives to defend the bank�� trading strategy. According to people familiar with the matter who spoke to the Wall Street Journal, a bet made on the value of the U.S. dollar versus the Japanese yen backfired on Goldman during the third quarter. When Goldman reported its third-quarter results last month, the company showed a drop in the revenue of its currency trading unit, and WSJ�� sources say the yen-dollar bet is what caused the slump.
Hot Sliver Companies To Own In Right Now: Softbank Corp (SFTBF)
SOFTBANK CORP. is a Japan-based company that provides digital information services. The Company has six business segments. The Mobile Communication segment provides cellular phone services and sells attached cellular phone terminals. The Broadband and Infrastructure segment provides high-speed Internet access services, Internet protocol (IP) phone service, and contents. The Fixed Communication segment provides transmission services for audio and data, as well as exclusive line and data center services. The Internet Culture segment is engaged in the Internet advertising, broadband portal and auction businesses. The Electronic Commerce (E-Commerce) segment sells personal computers (PCs), peripheral devices and software for PC use, as well as provides business-to-business and business-to-customer e-commerce services. The Others segment is involved in the broadcasting media, technology service, media marketing and overseas fund businesses.
Advisors' Opinion:- [By Sophia Yan]
Also poised to win big in the Alibaba IPO is Masayoshi Son, Japan's richest man. He is CEO of telecoms group Softbank (SFTBF), which has seen the value of its original $20 million investment soar to about $54 billion.
- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Japanese stocks rose Wednesday after a lower open, managing solid gains with most other Asian markets were closed for the Christmas holiday. The Nikkei Stock Average (JP:NIK) climbed 0.8% to 16,009.99, its first close above the 16,000 level since late 2007. The broader Topix ended with a more modest 0.1% rise. Seven & I Holdings Co. (JP:3382) (SVNDF) , operators of the 7-Eleven convenience-store chain, rose 1.5% as a Nikkei Asian Review report said it planned to pay about 楼5 billion yen to purchase nearly half of Bals, which runs home-and-kitchen-furnishings retailer Francfranc. Chip maker Renesas Electronics Corp. (JP:6723) (RNECY) was a strong performer, rallying 6.5% after suffering a sizeable drop in the previous session. On the downside, shares of Softbank Corp. (JP:9984) (SFTBF) fell 0.5%, after a separate article in the Nikkei saying that previously reported plans by the firm to buy T-Mobile US Inc. (TMUS) through its newly acquired Sprint (S) unit would value the transaction at more than 2 trillion yen ($19 billion) and would take place as early as next spring. Auto-maker stocks were mostly higher after trading mixed following the release of Japanese car-sales data for November. Toyota Motor Corp. (JP:7203) (TM) added 0.2%, Honda Motor Co. (JP:7267)
- [By Jonathan Berr]
Opposition to the latest wireless rumored wireless merger might have come as a surprise to Sprint’s CEO/pitchman Daniel Hesse and Masayoshi Son, the head of Japan’s SoftBank (SFTBF), which acquired a controlling interest in Sprint for $1.9 billion last year. For one thing, it’s hard to imagine the new company posing much of a competitive threat. A combined Sprint/T-Mobile would have 53 million users — significantly greater than their individual parts, but still less than half the 110 million served by AT&T and the 120 million subscribers under the Verizon flag.
Top 5 Services Stocks To Buy Right Now: Laboratory Corporation of America Holdings(LH)
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company?s specialty tests and related services comprise viral load measurements, genotyping and phenotyping, and host genetic factors for managing and treating HIV infections; cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests for diagnostic genetics; oncology tests for diagnosing and monitoring certain cancers and treatments; clinical trials testing for pharmaceutical companies, which conducts clinical research trials on diag nostic assays; forensic identity testing used in criminal proceedings and parentage evaluation services, as well as testing services in reconstruction cases; allergy testing; and occupational testing for the detection of drug and alcohol abuse. Its customers include independent physicians and physician groups, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. The company operates a network of 51 primary laboratories and approximately 1,700 patient service centers. In addition, it delivers a co-branded electronic health records Lite solution for physician practices. The company works with university, hospital, and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlingto n, North Carolina.
Advisors' Opinion:- [By Ben Levisohn]
Any time a stock falls more than 10% in a single day, you know something has gone wrong. Such is the case with medical-testing provider Laboratory Corporation of America (LH), or LabCorp.
- [By Holly LaFon]
We purchased a previous holding in our mid ca p fund, Laboratory Corp. of America Holdings (LH). LabCorp maintains a leading market position in an indust ry that continues to show promising growth potential du e to technological advances, aging demographics, health care cost containment, and preventative medicine. LabCorp maintains a solid balance sheet, generates a significant amount of free cash flow and has been returning value to shareholders through share repurchases. The company operates with an experienced management team that is conservative yet willing to take slight risks in order to grow the business long-term.From John Rogers (Trades, Portfolio)' Ariel Appreciation Fund first quarter 2014 letter. Also check out: John Rogers Undervalued Stocks John Rogers Top Growth Companies John Rogers High Yield stocks, and Stocks that John Rogers keeps buying Currently 0.00/512345
Rating: 0.0/5 (0 votes)
- [By Monica Wolfe]
Over the past week Chris Davis (Trades, Portfolio) of Davis Selected Advisers added to his holdings in Laboratory Corporation of America (LH).� The guru upped his stake 21.11% by purchasing 1,666,957 shares of the company�� stock.� He bought these shares at an average price of $91.37 per share, and since then the price per share is up about 1% to $92.57 per share.
Top 5 Services Stocks To Buy Right Now: Prumo Logistica SA (LLXL3)
Prumo Logistica SA, formerly LLX Logistica SA (LLX), is a Brazil-based company primarily engaged in the sector of port logistic services. The Company builds and develops the Acu Port, located in Sao Joao da Barra, in the north of the State of Rio de Janeiro. The Industrial Complex Acu Port has two port terminals (T1 and T2) and the capacity to handle various types of cargo, such as petroleum, iron ore, coal, solid and liquid bulk and general cargo. The Company�� subsidiaries include LLX Minas-Rio Logistica Comercial Exportadora SA, LLX Acu Operacoes Portuarias SA and LLX Brasil Operacoes Portuarias SA. In October, 2013, EIG LLX Holdings SARL reached a 52.82% stake in the ordinary share capital of the Company. Advisors' Opinion:- [By Denyse Godoy]
A committee of exchange executives, banks and brokerages developed the changes to the benchmark index. BM&FBovespa said on its website that it hadn�� made changes to the gauge�� methodology since its inception in 1968. LLX Logistica SA (LLXL3), the shipping unit that Batista founded, is the second-lowest priced stock on the Ibovespa after dropping 36 percent this year to 1.53 reais.
Top 5 Services Stocks To Buy Right Now: STAAR Surgical Company(STAA)
STAAR Surgical Company, together with its subsidiaries, engages in the design, development, manufacture, and sale of implantable lenses for the cataracts and refractive surgery. It offers intraocular lenses (IOL) that include silicone Toric IOL, which is used in cataract surgery to treat preexisting astigmatism; Preloaded Injector, a three-piece silicone or acrylic IOL preloaded into a single-use disposable injector; Aspheric IOLs that provide a clearer image than traditional spherical IOLs; and nanoFLEX IOL, a single-piece collamer aspheric IOL. The company also provides implantable collamer lenses (ICL) comprising VISIAN ICL and VISIAN Toric ICL to treat refractive disorders, such as myopia, hyperopia, and astigmatism. In addition, it sells surgical products and other related instruments, as well as manufactures AquaFlow device for the treatment of glaucoma. The company markets its products to health care providers, including surgical centers, hospitals, managed care pro viders, health maintenance organizations, group purchasing organizations, and government facilities primarily under the STAAR, Visian, Collamer, nanoFLEX, nanoPOINT, CentraFLOW, AquaPORT, Epiphany, and AquaFlow names. It distributes its products through directly employed representatives, independent sales representatives, and local distributors in the United States and internationally. The company was founded in 1982 and is headquartered in Monrovia, California.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Monday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Sarepta Therapeutics (NASDAQ: SRPT) and STAAR Surgical Company (NASDAQ: STAA). In trading on Monday, basic materials shares were relative laggards, down on the day by about 0.45 percent.
No comments:
Post a Comment